The embolization devices market size is projected to reach US$ 5.89 billion by 2031 from US$ 3.07 billion in 2024. The market is expected to register a CAGR of 9.9% during 2025-2031. Transforming embolization through clinical innovation is likely to bring new trends in the embolization devices market in the coming years.
The factors driving the embolization devices market include the rising prevalence of clinical conditions and burgeoning demand for minimally invasive techniques. Additionally, increasing awareness about various conditions and the development of new technologies are expected to contribute to market growth in the near future. Moreover, new product developments and marketing approvals are expected to create ample opportunities in the coming years.
North America is projected to dominate the embolization devices market with the largest share during the forecast period. Further, Asia Pacific is expected to register a significant CAGR owing to the increasing prevalence of cancer and other clinical conditions, leading to a higher demand for interventional procedures. Technological advancements also played a crucial role in the market growth. Innovations in embolization devices, such as drug-eluting beads, microcatheters, and novel coil designs, have enhanced the efficacy and safety profiles of embolization procedures. These advancements not only improve clinical outcomes but also reduce procedure times and post-operative complications, making them more attractive among healthcare providers and patients. The shift toward minimally invasive surgical techniques is another significant factor bolstering the popularity of the embolization technique. Minimally invasive procedures aid in reduced hospital stays, quicker recovery times, and lower risk of complications compared to open surgeries. As healthcare providers and patients increasingly recognize these advantages, the demand for embolization procedures is expected to rise.
Vascular diseases, including peripheral artery disease (PAD), aneurysms, and arteriovenous malformations (AVMs), are becoming more prevalent globally. These conditions have become particularly common among geriatric populations and individuals exposed to lifestyle-related risk factors. Peripheral vascular disease (PVD) consists of PAD and venous disease. According to the article "Income-Related Peripheral Artery Disease Treatment," published in the National Library of Medicine in 2022, more than 200 million people worldwide suffer from PAD, and ~10% of the affected people in Western Europe and North America were aged 50 years and above. The prevalence of PVD ranges from 3% in patients aged >55 years and 11% in patients aged >65 years to 20% in patients aged >75.
The cases of neurovascular conditions such as strokes and brain aneurysms are also on the rise across the world. As per the Brain Aneurysm Foundation estimates, 6.8 million people in the US have an unruptured brain aneurysm. Each year, nearly 30,000 Americans suffer a brain aneurysm rupture, often requiring immediate intervention through embolization techniques. Almost 500,000 people die worldwide due to brain aneurysms each year. Brain aneurysms are most prevalent in people from the age group of 35–60, and most aneurysms develop after the age of 40. Additionally, ruptured brain aneurysms account for 3–5% of all new strokes.
As per the World Health Organization (WHO), postpartum hemorrhage is the foremost cause of maternal mortality globally. Nearly 14 million women suffer from this condition each year, resulting in approximately 70,000 post-partem deaths worldwide. Additionally, as per the Institute for Functional Medicine, the prevalence of uterine fibroids has increased by 78.82% in the past 30 decades, growing from 126.41 million to 226.05 million in terms of number of cases. These clinical conditions can be effectively treated using embolization devices, which are designed to block abnormal or excessive blood flow within blood vessels. The technique is preferred due to its minimally invasive nature. Embolization involves the deliberate occlusion of blood vessels to treat conditions such as aneurysms, postpartum hemorrhage, uterine fibroids, and certain types of tumors. It is used to control severe bleeding after childbirth when conventional methods are ineffective, as well as block the blood supply to fibroids, causing them to shrink and symptoms to improve.
Small and big companies operating in the embolization devices market are increasingly adopting strategies such as geographic expansions, new product developments, and technological advancements to boost their revenues. A few of the noteworthy product developments and approvals in the embolization devices market, which are expected to drive its growth in the coming years, are mentioned below.
Therefore, new product developments and marketing approvals are anticipated to create lucrative growth opportunities in the embolization devices market.
Key segments that form the foundation of the embolization devices market analysis are product type, application, and end user.
The geographical scope of the embolization devices market report is mainly divided into five regions: North America, Asia Pacific, Europe, and Middle East & Africa, and South & Central America. North America held a significant share of the market in 2024. The embolization devices market in North America is driven by the region’s advanced healthcare infrastructure, increasing prevalence of vascular diseases, and growing adoption of minimally invasive procedures. Technological advancements have led to a significant enhancement in the precision and safety of embolization techniques, making them a preferred choice for treating conditions such as aneurysms, arteriovenous malformations, and tumors. The high patient awareness about various medical conditions and treatment options, strong healthcare reimbursement systems, and the presence of leading medical device companies contribute to the market’s maturity in North America. Additionally, public health campaigns play a crucial role in promoting embolization procedures. Ongoing research and clinical trials are further expanding the scope of embolization technologies, with a particular focus on biodegradable and drug-eluting embolic agents. While the US leads in terms of adoption and innovation, Canada and Mexico are progressively increasing their market participation through supportive policies and infrastructure development. However, disparities in healthcare access across rural and urban settings remain a challenge. As a result, North American countries continue to attract significant investments, along with prompting collaborations among hospitals, research institutes, and device manufacturers, ensuring sustained development and innovation in embolization technologies.
The regional trends and factors influencing the Embolization Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Embolization Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 3.07 Billion |
| Market Size by 2031 | US$ 5.89 Billion |
| Global CAGR (2025 - 2031) | 9.9% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Embolization Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Embolization Devices Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The embolization devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
The “Embolization Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
The embolization devices market is estimated to register a CAGR of 9.9% during the forecast period.
The embolization devices market is estimated to reach a value of US$ 5.89 billion by 2031.
Medtronic Plc,; Cook Medical Holdings LLC,; Stryker Corp,; Boston Scientific Corp,; Terumo Corp,; Johnson & Johnson,; Abbott Laboratories,; NeuroSafe Medical Co. Ltd,; Wallaby Medical,; Sirtex Medical Ltd,; GEM srl,; Balt,; Lepu Medical Technology Beijing Co Ltd,; INVAMED,; Meril Life Sciences Pvt Ltd,; Merit Medical Systems Inc,; and Lifetech Scientific Corp are among the key players operating in the embolization devices market.
North America dominated the market in 2024.
The rising prevalence of clinical conditions and burgeoning demand for minimally invasive techniques are the most influential factors responsible for the market growth.